Ticker
TRDACompany Name
ENTRADA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earning Before Interest & Taxes (EBIT) | EBIT per Share | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ -76.91M | $ -1.86 | 1 | 41.34M |
3/31/2025 | $ 23.81M | $ 0.58 | 1 | 41.07M |
12/31/2024 | $ 66.48M | $ 1.78 | 1 | 37.31M |
9/30/2024 | $ 76.42M | $ 1.88 | 1 | 40.63M |
6/30/2024 | $ 110.38M | $ 3.23 | 1 | 34.18M |
3/31/2024 | $ 40.51M | $ 1.21 | 1 | 33.5M |
12/31/2023 | $ 12.06M | $ 0.36 | 1 | 33.05M |
9/30/2023 | $ -20.82M | $ -0.63 | 1 | 33.28M |
6/30/2023 | $ -63.22M | $ -1.91 | 1 | 33.16M |
3/31/2023 | $ -74.32M | $ -2.3 | 1 | 32.37M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT / (Shares WA * Share Factor)
(=) EBITPS
EBITPS for ENTRADA THERAPEUTICS INC is calculated as follows: EBIT [ $ -26.52M ] / (Shares WA [ 8M ] * Share Factor [ 1 ])
(=) EBITPS [ $ -3.32 ]
Minimum
Dec 31, 2021
Maximum
Jun 30, 2024
Average
Median
filtered constituents | 3.79K |
---|---|
min | $ -9.72 |
max | $ 10.76 |
average | $ 1.16 |
median | $ 0.38 |
std | $ 3.42 |